Pharming Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	0.38	-11.84	-10.55	13.67	16	37.75
Depreciation & Amortization	9.83	10.19	10.13	9.33	9.17	8.31
Other Amortization	0.85	0.85	0.88	-	-	-
Loss (Gain) From Sale of Assets	-	-	-21.28	-	-	-
Asset Writedown & Restructuring Costs	5.03	5.03	4.92	3.86	10.44	-
Loss (Gain) From Sale of Investments	0.17	-4.99	0.93	-11.06	-0.11	-0.07
Loss (Gain) on Equity Investments	0.76	1.76	0.29	1.08	-0.69	-0.36
Stock-Based Compensation	11.9	11.25	9.25	6.39	9.06	6.54
Other Operating Activities	20.43	-3.97	5.09	-0.44	-1.05	35.38
Change in Accounts Receivable	6.71	-6.78	-18.54	2.36	5.92	-7.04
Change in Inventory	1.24	-0.5	-14.43	-15.02	-6.15	-4.93
Change in Accounts Payable	-2.94	-2.77	16.23	11.99	-5.19	7.02
Change in Other Net Operating Assets	-1.04	-0.02	-0.22	0.27	0.47	1.04
Operating Cash Flow	53.33	-1.8	-17.3	22.46	37.84	83.63
Operating Cash Flow Growth	11725.28%	-	-	-40.65%	-54.75%	12.78%
Capital Expenditures	-0.61	-0.79	-1.44	-1.38	-10.74	-4.66
Cash Acquisitions	-57.48	-	-	-	-	-
Sale (Purchase) of Intangibles	-0.01	-0.01	21.25	-0.6	-5.98	-10.64
Investment in Securities	74.61	32.41	-149.2	7.3	-4.59	-0.33
Investing Cash Flow	16.51	31.62	-129.39	5.32	-21.31	-15.63
Long-Term Debt Issued	-	104.54	-	-	-	142.83
Long-Term Debt Repaid	-	-138.93	-4.04	-3.31	-3.22	-59.42
Net Debt Issued (Repaid)	-4.39	-34.39	-4.04	-3.31	-3.22	83.41
Issuance of Common Stock	16.66	5.58	8.13	2.28	4.72	2.79
Other Financing Activities	-14.01	-5.6	-5.13	-3.95	-29.45	-25.51
Financing Cash Flow	-1.75	-34.41	-1.04	-4.98	-27.95	60.69
Foreign Exchange Rate Adjustments	3.62	-2.21	2.13	-7.38	-1.83	2.13
Net Cash Flow	71.71	-6.8	-145.6	15.42	-13.24	130.81
Free Cash Flow	52.72	-2.59	-18.74	21.08	27.1	78.97
Free Cash Flow Growth	-	-	-	-22.21%	-65.68%	10.44%
Free Cash Flow Margin	14.55%	-0.87%	-7.64%	10.25%	13.63%	37.22%
Free Cash Flow Per Share	0.08	-0.00	-0.03	0.03	0.04	0.12
Cash Interest Paid	6.14	5.6	5.13	3.95	4.45	2.14
Cash Income Tax Paid	7.19	15.58	0.66	1.24	-	2.66
Levered Free Cash Flow	43.51	0.24	8.06	16.23	-17.14	44.3
Unlevered Free Cash Flow	52.45	5.7	11.78	19.58	-13.33	48.01
Change in Working Capital	3.99	-10.07	-16.96	-0.39	-4.96	-3.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.